共查询到20条相似文献,搜索用时 234 毫秒
1.
国内护理健康教育系统评价/Meta分析现状 总被引:1,自引:1,他引:0
陆旭婷 《中华现代护理杂志》2010,16(9):1107-1108
健康教育是护理人员干预疾病的一种重要手段,尤其是随着循证护理学兴起,健康教育愈来愈受护理研究者和实践者的重视。本文通过综述国内护理健康教育系统评价/Meta分析研究,总结目前的研究成果,指出研究中的不足和今后的方向,以供同道参考。 相似文献
2.
[目的]系统评价心理干预及健康教育对冠心病心绞痛病人生活质量的疗效,为临床护理提供循证依据。[方法]检索相关数据库,分析软件为RevMan 5.3,对与本研究相关的随机对照试验(RCT)研究中收集的数据进行综合分析。[结果]采用生活质量量表(SF-36)评价病人的生活质量,随机效应模型结果显示,与对照组相比,干预组病人生活质量明显得到改善,社会功能[MD=14.09,95%CI(12.61,15.58),P<0.00001]、睡眠质量[MD=3.35,95%CI(2.71,3.99),P<0.00001]、自我管理[MD=9.97,95%CI(9.05,10.89),P<0.00001]、生理功能[MD=11.11,95%CI(9.17,13.05),P<0.00001];采用西雅图心绞痛调查量表进行评价,随机效应模型结果显示,与对照组相比,干预组病人生活质量得到明显改善,身体活动受限度[MD=7.34,95%CI(6.41,8.26),P<0.00001]、疾病认知度[MD=1.80,95%CI(1.52,2.08),P<0.00001]、心绞痛发作[MD=0.79,95%CI(0.50,1.08),P<0.00001]、心绞痛稳定[MD=0.51,95%CI(0.44,0.57),P<0.00001]、治疗满意度[MD=2.39,95%CI(0.87,3.91),P=0.002]。[结论]在常规治疗护理的基础上对冠心病心绞痛病人给予心理干预及健康教育,可有效改善病人的生活质量,具有良好的临床应用价值。 相似文献
3.
4.
健康教育对帕金森病疗效影响的Meta分析 总被引:1,自引:0,他引:1
目的 运用Meta分析的方法探讨健康教育对帕金森病治疗效果的影响.方法 检索主要的医学数据库,按照一定的纳入标准和排除标准纳入文献并对纳入的文献进行质最评价,采用Review Manager v5.0软件进行统计学处理,从依从性、跌倒、压疮、帕金森病统一评分量表(Unified Parkinson's Disease Rating Scale,UPDRS)、帕金森病生活质量问卷(PDQ-39)、抑郁情绪几个方面对健康教育的效果进行评价.结果 健康教育组与对照组之间在依从性方面差异有统计学意义,而在跌倒、压疮、UPDRS、PDQ-39、抑郁情绪方面两组之间差异无统计学意义(P>0.05).结论 目前医护人员针对帕金森病患者及其家属进行的健康教育在一定程度上对患者的治疗具有积极作用,但仍需进一步改进,以便进一步明确健康教育在疾病治疗中的作用. 相似文献
5.
6.
7.
目的系统评价针灸治疗脓毒症患者的疗效和安全性。方法计算机检索PubMed、EMbase、The Cochrane Library、CNKI、WanFang Data、VIP和CBM数据库,搜集针灸治疗脓毒症患者的随机对照试验(RCT),检索时限均从建库至2019年10月1日。由2位评价员独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan 5.3软件进行Meta分析。结果纳入20个研究,共1 337例患者。Meta分析结果显示:针灸+常规方法治疗脓毒症患者在28天病死率[RR=0.69,95%CI(0.5,0.96),P=0.03]、治疗后第3天APACHEⅡ评分[MD=-2.4,95%CI(-3.68,-1.12),P=0.0002]、治疗后第7天APACHEⅡ评分[MD=-4.37,95%CI(-6.32,-2.21),P<0.0001]、ICU住院时长[MD=-1.54,95%CI(-2.81,-0.27),P=0.02]、胃肠道功能改善有效率[RR=1.5,95%CI(1.09,2.06),P=0.01]、治疗后第7天PCT浓度[MD=-2.23,95%CI(-3.33,-1.13),P<0.001]和TNF-α浓度[MD=-14.86,95%CI(-23.74,-5.97),P=0.001]方面,与常规治疗组的差异均具有统计学意义。但在治疗后第7天CD8^+记数[MD=1.65,95%CI(-0.32,3.62),P=0.1]方面,二者差异无统计学意义。结论现有有限证据表明,针灸可能是潜在的治疗脓毒症患者的方法之一。受纳入研究数量和质量限制,上述结论尚需开展更多高质量研究予以验证。 相似文献
8.
目的系统评价瑜伽治疗下背痛的有效性。方法计算机检索Web of Science、BBSCO Academic Source Complete、Elsevier ScienceDirect、Scopus、PubMed、WanFang Data和CNKI数据库,搜集有关瑜伽治疗下背痛有效性的随机对照试验(randomized controlled trial,RCT),检索时限均从建库至2019年11月4日。由2名研究者独立筛选文献、提取资料并评价纳入研究的偏倚风险后,采用RevMan 5.3软件进行Meta分析。结果共纳入14个RCT,包括1 684例患者。Meta分析结果显示:与常规治疗相比,瑜伽治疗下背痛的RMDQ问卷评分更低[MD=–1.86,95%CI(–2.39,–1.33),P<0.000 01],其差异有统计学意义。亚组分析结果显示,不同锻炼频率、下背痛程度、致因、干预周期、样本量等亚组的瑜伽治疗效果均优于常规治疗组,差异均有统计学意义。结论现有证据表明,瑜伽治疗下背痛能取得更好疗效。受纳入研究数量和质量限制,上述结论尚需开展更多高质量研究予以验证。 相似文献
9.
目的系统评价全世界脑胶质瘤干预类系统评价/Meta分析(SR/MA)的方法学和报告质量。方法计算机检索Pub Med、EMbase、h e Cochrane Library、CNKI、CBM等数据库,纳入脑胶质瘤干预类SR/MA,检索时限截至2013年7月。由2位研究者独立筛选文献,而后采用AMSTAR和PRISMA清单对纳入研究的方法学与报告质量进行评价与分析。结果共纳入51个SR/MA。结果显示:纳入研究中方法学质量存在的主要问题有无研究设计方案、检索策略不全面、纳入研究出版物形式局限、未评价文章发表偏倚及未说明相关利益冲突;纳入研究的报告质量存在的主要问题是检索策略的报告不规范、纳入研究质量和偏倚风险报道不全面和研究结果表述不全(部分缺乏森林图、综合结果的估计值和可信区间、异质性检验结果)。结论脑胶质瘤干预类SR/MA的方法学质量和报告质量还存在不同程度的问题,该领域研究者应提高SR/MA制作的科学性和规范性,并遵循PRISMA进行报告。 相似文献
10.
目的:评价近5年我国护理核心期刊发表的干预性研究系统评价的方法学质量,为研究者及审稿人规范制作及审阅系统评价提供参考。方法:在中国知网和万方数据库中,检索2015-2019年发表在我国护理核心期刊的干预性研究系统评价,描述研究涉及的主题,并采用新版系统评价方法学质量评价工具(AMSTAR 2)进行评价。结果:共纳入文献507篇,其中80.9%可信度为极低级。主要问题包括未提及前期研究方案(98.8%)、发表偏倚分析与讨论不充分(71.4%)、文献检索策略不全面(55.8%)、PICO各要素界定不具体(41.4%)等。结论:纳入的系统评价方法学质量总体偏低,亟待通过研究者和审稿人共同努力,提升系统评价计划书的注册、检索策略的全面性和透明性、发表偏倚的考虑等方面的质量,为实践者提供更为可靠的决策依据。 相似文献
11.
Acupuncture for Acute Postoperative Pain after Back Surgery: A Systematic Review and Meta‐analysis of Randomized Controlled Trials 下载免费PDF全文
Young‐Hun Cho MS Chang‐Kyu Kim Kwang‐Ho Heo MD PhD Myeong Soo Lee PhD In‐Hyuk Ha MD PhD Dong Wuk Son MD PhD Byung Kwan Choi MD PhD Geun‐Sung Song MD PhD Byung‐Cheul Shin MD PhD 《Pain practice》2015,15(3):279-291
12.
13.
Rodrigo R.N. Rizzo Flavia C. Medeiros Leandro G. Pires Rafael M. Pimenta James H. McAuley Mark P. Jensen Leonardo O.P. Costa 《The journal of pain》2018,19(10):1103.e1-1103.e9
The potential benefits of combining pain education (PE) with clinical hypnosis (CH) has not yet been investigated in individuals with chronic pain. A total of 100 patients with chronic nonspecific low back pain were randomized to receive either: 1) PE alone, or 2) PE with CH. Outcomes were collected by a blinded assessor at 2 weeks and 3 months after randomization. The primary outcomes were average pain intensity, worst pain intensity (both assessed with 11-point numeric rating scales), and disability (24-item Roland Morris Disability Questionnaire) at 2 weeks. At 2 weeks, participants who received PE with CH reported lower worst pain intensity (mean difference?=?1.35 points, 95% confidence interval [CI]?=?.32–2.37) and disability (mean difference?=?2.34 points, 95% CI?=?.06–4.61), but not average pain intensity (mean difference?=?.67 point, 95% CI?=??.27 to 1.62), relative to participants who received PE alone. PE with CH participants also reported more global perceived benefits at 2 weeks (mean difference?=??1.98 points, 95% CI?=??3.21 to ?.75). At 3 months, participants who received PE with CH reported lower worst pain intensity (mean difference?=?1.32 points, 95% CI?=?.29–2.34) and catastrophizing (mean difference?=?5.30 points, 95% CI?=?1.20–9.41). No adverse effects in either treatment condition were reported. To our knowledge, this is the first trial showing that additional use of hypnosis with PE results in improved outcomes over PE alone in patients with chronic nonspecific low back pain.
Perspective
This study provides evidence supporting the efficacy of another treatment option for teaching patients to self-manage chronic low back pain that has a relatively low cost and that can be offered in groups. 相似文献14.
Barnet Eskin Richard D. Shih Frederick W. Fiesseler Brian W. Walsh John R. Allegra Michael E. Silverman Dennis G. Cochrane David F.E. Stuhlmiller Oliver L. Hung Alex Troncoso Diane P. Calello 《The Journal of emergency medicine》2014
Background
Although oral corticosteroids are commonly given to emergency department (ED) patients with musculoskeletal low back pain (LBP), there is little evidence of benefit.Objective
To determine if a short course of oral corticosteroids benefits LBP ED patients.Methods
Design: Randomized, double-blind, placebo-controlled trial. Setting: Suburban New Jersey ED with 80,000 annual visits. Participants: 18–55-year-olds with moderately severe musculoskeletal LBP from a bending or twisting injury ≤ 2 days prior to presentation. Exclusion criteria were suspected nonmusculoskeletal etiology, direct trauma, motor deficits, and local occupational medicine program visits. Protocol: At ED discharge, patients were randomized to either 50 mg prednisone daily for 5 days or identical-appearing placebo. Patients were contacted after 5 days to assess pain on a 0–3 scale (none, mild, moderate, severe) as well as functional status.Results
The prednisone and placebo groups had similar demographics and initial and discharge ED pain scales. Of the 79 patients enrolled, 12 (15%) were lost to follow-up, leaving 32 and 35 patients in the prednisone and placebo arms, respectively. At follow-up, the two arms had similar pain on the 0–3 scale (absolute difference 0.2, 95% confidence interval [CI] −0.2, 0.6) and no statistically significant differences in resuming normal activities, returning to work, or days lost from work. More patients in the prednisone than in the placebo group sought additional medical treatment (40% vs. 18%, respectively, difference 22%, 95% CI 0, 43%).Conclusion
We detected no benefit from oral corticosteroids in our ED patients with musculoskeletal LBP. 相似文献15.
Purpose
The evidence has suggested that resveratrol has anti-inflammatory effect; however, the results are inconsistent and inconclusive. The aim of this study was to assess the effect of resveratrol supplementation on the levels of inflammatory markers through a systematic review and meta-analysis of available randomized controlled trials (RCTs).Methods
A search strategy was completed using Medline, ISI Web of Science, Directory of Open Access Journal, SID, ProQuest, Cochrane Library, Scopus, and EMBASE up to May 2017, to identify placebo-controlled RCTs that assessed resveratrol effects on circulating (serum and plasma) inflammatory markers (interleukin [IL]-6, tumor necrosis factor–α [TNF-α], and high-sensitivity C-reactive protein [hs-CRP]) among adult participants aged 17 years and older in 17 RCTs with a total of 736 subjects. The evaluation of study quality was performed using the Jadad scale. Weighted mean difference (WMD) was calculated for evaluating the changes in the inflammatory markers using fixed-effects or random-effects models. We performed subgroup and sensitivity analyses to evaluate the heterogeneity of the studies.Findings
Seventeen RCTs, including 736 subjects, fulfilled the eligibility criteria and were selected for analyses. The results of meta-analysis found significant reductions in the level of TNF-α (WMD, –0.44; 95% CI, –0.71 to –0.164; P?=?0.002; Q statistic?=?21.60; I2?=?49.1%; P?=?0.02) and hs-CRP (WMD, –0.27; 95% CI, –0.5 to –0.02; P?=?0.033; Q statistic?=?26.95; I2?=?51.8%; P?=?0.013) after supplementation with resveratrol. Resveratrol supplementation had no significant effect on the level of IL-6 (WMD, –0.16; 95% CI, –0.53 to 0.20; P?=?0.38; Q statistic?=?36.0; I2?=?72.3%; P?=?0.001). Statistically significant heterogeneity was observed for the type of sample in IL-6 and study duration in inflammatory markers IL-6, TNF-α, and hs-CRP.Implications
Available evidence from RCTs suggests that resveratrol supplementation significantly reduced TNF-α and hs-CRP levels. Significant improvement in inflammatory markers support resveratrol as an adjunct to pharmacologic management of metabolic diseases. 相似文献16.
17.
18.
19.
20.
Gema Bodes Pardo Enrique Lluch Girbés Nathalie A. Roussel Tomás Gallego Izquierdo Virginia Jiménez Penick Daniel Pecos Martín 《Archives of physical medicine and rehabilitation》2018,99(2):338-347